Efficacy and Safety of Probiotics in Neonatal Hyperbilirubinemia
Status:
Unknown status
Trial end date:
2017-11-01
Target enrollment:
Participant gender:
Summary
Neonatal Jaundice occurs in 60% of term infants and 80% of premature infants. Although it is
transient, it is associated with high rate of readmission of patients in the first week of
infancy. Neonatal jaundice can cause neurological complications and kernicterus. Considering
the fact that there have been a lot of studies on probiotic role in management of necrotizing
enterocolitis (NEC) and few studies on their role in neonatal jaundice, we carried out this
study to determine the efficacy and safety of probiotics in neonatal hyperbilirubinemia in
infants hospitalized in children hospital in Bandar Abbas.